Tore Jarl Gutteberg

Emeritus
ved Institutt for medisinsk biologi ved UiT Norges arktiske universitet
Overlege
ved Medisinsk klinikk ved Universitetssykehuset Nord-Norge HF

Resultater Resultater

“The effect of 48-weeks azithromycin therapy on levels of soluble biomarkers associated with HIV-associated chronic lung disease”.

Hameiri-Bowen, Dan; Yindom, Louis-Marie; Sovershaeva, Evgeniya; Bandason, Tsitsi; Mayini, Justin; M Rehman, Andrea; Simms, Victoria; Gift Ngwira, Lucky; Flægstad, Trond; Gutteberg, Tore Jarl mfl.. 2023, International Immunopharmacology. UIT, LSTM, UoL, UoO, UNN, MLW, BRTI, MRCVitenskapelig artikkel

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.

Howe, Anita Y.M.; Rodrigo, Chaturaka; Cunningham, Evan B.; Douglas, Mark W.; Dietz, Julia; Grebely, Jason; Popping, Stephanie; Sfalcin, Javier Alejandro; Parczewski, Milosz; Sarrazin, Christoph mfl.. 2022, JHEP Reports. MMA, Uu, AUSTRALIA, UdSdRTV, UTA, CANADA, JWGFaM, PUM, SPANIA, ARGENTINA, SYDNEY, OUS, KÜ, UNN, UNIC, UBC, UNSW, EMC, HCU, JOSHOSP, AP-HPVitenskapelig artikkel

Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection.

Hameiri-Bowen, Dan; Sovershaeva, Evgeniya; Flaegstad, Trond; Gutteberg, Tore Jarl; Ngwira, Lucky Gift; Simms, Victoria; Rehman, Andrea M.; McHugh, Grace; Bandason, Tsitsi; Ferrand, Rashida A. mfl.. 2021, AIDS (London). UIT, UoL, LSTM, UNN, UoO, MLW, ØVRIGE, BRTIVitenskapelig artikkel

Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical Trial.

Ferrand, Rashida A.; McHugh, Grace; Rehman, Andrea M.; Mujuru, Hilda A.; Simms, Victoria; Majonga, Edith D.; Nicol, Mark P.; Flægstad, Trond; Gutteberg, Tore Jarl; Gonzalez-Martinez, carmen mfl.. 2020, JAMA Network Open. UIT, UoZ, UoM, UOPVP, UoL, UNN, UoO, UCT, MALAWI, BRTI, UWA, MRCVitenskapelig artikkel

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway.

Kjellin, Midori; Kileng, Hege; Akaberi, Dario; Palanisamy, Navaneethan; Duberg, Ann-Sofi; Danielsson, Astrid; Kristiansen, Magnhild Gangsøy; Nöjd, Johan Edvin; Aleman, Soo; Gutteberg, Tore Jarl mfl.. 2019, Scandinavian Journal of Gastroenterology. Uu, UIT, AKADEMISKA, KAROLINSKA, ORU, UNN, FL, RH, HELSENSS, FREIBURG, KIVitenskapelig artikkel

1 - 5 av 77 | Neste | Siste »